Clonitazene is an opioid analgesic of approximately three times the potency of morphine. It is related to etonitazene, an opioid of significantly higher potency. Clonitazene is not currently marketed. It is a controlled substance; in the United States it is a Schedule I Narcotic controlled substance with a DEA ACSCN of 9612 and an annual manufacturing quota of zero.
|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||386.88 g/mol g·mol−1|
|3D model (JSmol)|
|(what is this?)|
- Hunger, A.; Kebrle, J.; Rossi, A.; Hoffmann, K. (1 October 1957). "Synthese basisch substituierter, analgetisch wirksamer Benzimidazol-Derivate" [Synthesis of analgesically active benzimidazole derivatives with basic substitutions]. Experientia. 13 (10): 400–401. doi:10.1007/BF02161116. PMID 13473817.
|This analgesic-related article is a stub. You can help Wikipedia by expanding it.|